OA10352A - Combination of atovaquone with proguanil for the treatment of protozoal infections - Google Patents
Combination of atovaquone with proguanil for the treatment of protozoal infections Download PDFInfo
- Publication number
- OA10352A OA10352A OA60668A OA60668A OA10352A OA 10352 A OA10352 A OA 10352A OA 60668 A OA60668 A OA 60668A OA 60668 A OA60668 A OA 60668A OA 10352 A OA10352 A OA 10352A
- Authority
- OA
- OAPI
- Prior art keywords
- proguanil
- naphthoquinone
- atovaquone
- hydroxy
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929224739A GB9224739D0 (en) | 1992-11-26 | 1992-11-26 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
OA10352A true OA10352A (en) | 2001-10-22 |
Family
ID=10725687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA60668A OA10352A (en) | 1992-11-26 | 1995-05-26 | Combination of atovaquone with proguanil for the treatment of protozoal infections |
Country Status (38)
Country | Link |
---|---|
US (3) | US5998449A (fr) |
EP (1) | EP0670719B1 (fr) |
JP (1) | JP3768231B2 (fr) |
KR (1) | KR100294802B1 (fr) |
CN (1) | CN1087935C (fr) |
AP (1) | AP517A (fr) |
AT (1) | ATE191340T1 (fr) |
AU (1) | AU685408B2 (fr) |
BG (1) | BG62595B1 (fr) |
CA (1) | CA2150234E (fr) |
CY (1) | CY2193B1 (fr) |
CZ (2) | CZ289171B6 (fr) |
DE (1) | DE69328307T2 (fr) |
DK (1) | DK0670719T3 (fr) |
ES (1) | ES2145114T3 (fr) |
GB (1) | GB9224739D0 (fr) |
GR (1) | GR3033745T3 (fr) |
HK (1) | HK1004468A1 (fr) |
HU (1) | HU225918B1 (fr) |
IL (1) | IL107755A (fr) |
MX (1) | MX9307402A (fr) |
MY (1) | MY114241A (fr) |
NO (1) | NO313225B1 (fr) |
NZ (1) | NZ257901A (fr) |
OA (1) | OA10352A (fr) |
PE (1) | PE55694A1 (fr) |
PL (1) | PL174323B1 (fr) |
PT (1) | PT670719E (fr) |
RO (1) | RO119280B1 (fr) |
RU (1) | RU2108092C1 (fr) |
SA (1) | SA93140434B1 (fr) |
SG (1) | SG45387A1 (fr) |
SI (1) | SI9300614A (fr) |
SK (1) | SK281559B6 (fr) |
TW (1) | TW253835B (fr) |
UA (1) | UA45948C2 (fr) |
WO (1) | WO1994012164A1 (fr) |
ZA (1) | ZA938832B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
GB9424013D0 (en) * | 1994-11-29 | 1995-01-18 | Wellcome Found | Medicaments |
DE19737463A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
GB9822681D0 (en) * | 1998-10-16 | 1998-12-09 | Vitabiotics Ltd | Method of treatment |
CZ294903B6 (cs) * | 1999-04-09 | 2005-04-13 | Glaxo Group Limited | Kombinační prostředek pro léčení malárie |
US7104076B2 (en) * | 2004-06-24 | 2006-09-12 | Carrier Corporation | Lubricant return schemes for use in refrigerant cycle |
ITMI20070941A1 (it) * | 2007-05-09 | 2008-11-10 | Chimico Internazi0Nale S P A L | Procedimento per la preparazione di naftochinoni trans2,3-disostituiti |
EP2467358B1 (fr) * | 2009-08-20 | 2014-07-23 | IPCA Laboratories Limited | Nouveau complexe pour le traitement et/ou la prophylaxie d'infections parasitaires |
US20180055835A1 (en) | 2016-08-25 | 2018-03-01 | Immune Therapeutics Inc. | Method for Treating And Preventing Protozoal Infections |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2533648A (en) * | 1949-03-05 | 1950-12-12 | Joseph H Warburg | Circular saw making |
NL6411993A (fr) * | 1963-10-18 | 1965-04-20 | ||
US3347830A (en) * | 1964-07-30 | 1967-10-17 | Grace W R & Co | Process of polymerizing formaldehyde |
GB1141735A (en) * | 1966-11-23 | 1969-01-29 | Pfizer & Co C | Pharmaceutical anti-tumor composition |
NL6817526A (fr) * | 1968-01-24 | 1969-07-28 | ||
US3655699A (en) * | 1970-03-02 | 1972-04-11 | Pfizer | Analogues of lapachol as antitumor agents |
DE2601458A1 (de) * | 1975-01-20 | 1976-07-22 | Ciba Geigy Ag | Loesliche, von phenylindandiaminen abgeleitete polyamide |
EP0002228B1 (fr) * | 1977-11-22 | 1984-02-29 | The Wellcome Foundation Limited | Dérivés d'hydroxynaphtochinones, leurs préparations utilisées dans le traitement et la prévention de la theilériose chez le bétail et les moutons; leurs procédés de préparation; dérivés de naphtoquinones |
US4485116A (en) * | 1981-10-16 | 1984-11-27 | Hudson Alan T | Antiprotozoal compounds |
US4485117A (en) * | 1981-10-16 | 1984-11-27 | Hudson Alan T | Antiprotozoal compounds |
US5053432A (en) * | 1983-04-14 | 1991-10-01 | Burroughs Wellcome Co. | Naphthoquinone derivatives |
GB8310141D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Naphthoquinone derivatives |
GB8310140D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Antiprotozoal agents |
JPS59196467A (ja) * | 1983-04-23 | 1984-11-07 | Nissan Motor Co Ltd | 車輪速及びまたは車輪加減速度検出方法 |
US5225184A (en) * | 1988-08-16 | 1993-07-06 | Burroughs Wellcome Co. | Medicaments |
US5206268A (en) * | 1988-08-16 | 1993-04-27 | Burroughs Wellcome Co. | Medicaments |
HU208624B (en) * | 1988-08-16 | 1993-12-28 | Wellcome Found | Process for producing pharmaceutical compositions containing naphtoquinone derivatives effective against pneumocystis infections |
GB8819477D0 (en) * | 1988-08-16 | 1988-09-21 | Wellcome Found | Medicaments |
GB8921516D0 (en) * | 1989-09-22 | 1989-11-08 | Wellcome Found | Medicaments |
GB8923254D0 (en) * | 1989-10-16 | 1989-12-06 | Wellcome Found | Medicaments |
US5014737A (en) * | 1989-11-13 | 1991-05-14 | Allan Berman | Quartz integrated trough/sump recirculating filtered high-purity chemical bath |
GB9121316D0 (en) * | 1991-10-09 | 1991-11-20 | Wellcome Found | Heterocyclic compounds |
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
GB9226905D0 (en) * | 1992-12-24 | 1993-02-17 | Wellcome Found | Pharmaceutical preparation |
US5529994A (en) * | 1993-05-05 | 1996-06-25 | Palo Alto Medical Foundation | Treatment for toxoplasmosis |
DE69400631T2 (de) * | 1993-05-05 | 1997-02-27 | Palo Alto Medical Foundation, Palo Alto, Calif. | Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose |
US5733932A (en) * | 1995-01-06 | 1998-03-31 | The Picower Institute For Medical Research | Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions |
US5827543A (en) * | 1995-12-07 | 1998-10-27 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of urogenital disorders |
US5744168A (en) * | 1995-12-07 | 1998-04-28 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
US5747476A (en) * | 1996-07-17 | 1998-05-05 | Mortar & Pestle Veterinary Pharmacy, Inc. | Treatment of equine protozoal myeloencephalitis |
ZA983331B (en) * | 1997-05-01 | 1998-10-27 | Allegheny University Of The He | Method for treating protozoal infections |
AUPO821097A0 (en) * | 1997-07-25 | 1997-08-14 | Cultor Ltd. | A prophylactic |
DE19737463A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
CZ294903B6 (cs) * | 1999-04-09 | 2005-04-13 | Glaxo Group Limited | Kombinační prostředek pro léčení malárie |
-
1992
- 1992-11-26 GB GB929224739A patent/GB9224739D0/en active Pending
-
1993
- 1993-11-25 KR KR1019950702071A patent/KR100294802B1/ko not_active IP Right Cessation
- 1993-11-25 PT PT94900254T patent/PT670719E/pt unknown
- 1993-11-25 EP EP94900254A patent/EP0670719B1/fr not_active Expired - Lifetime
- 1993-11-25 NZ NZ257901A patent/NZ257901A/en not_active IP Right Cessation
- 1993-11-25 DE DE69328307T patent/DE69328307T2/de not_active Expired - Lifetime
- 1993-11-25 AU AU55322/94A patent/AU685408B2/en not_active Expired
- 1993-11-25 IL IL10775593A patent/IL107755A/xx not_active IP Right Cessation
- 1993-11-25 ES ES94900254T patent/ES2145114T3/es not_active Expired - Lifetime
- 1993-11-25 CZ CZ19951192A patent/CZ289171B6/cs not_active IP Right Cessation
- 1993-11-25 CA CA002150234A patent/CA2150234E/fr not_active Expired - Lifetime
- 1993-11-25 SG SG1996005505A patent/SG45387A1/en unknown
- 1993-11-25 CN CN93114723A patent/CN1087935C/zh not_active Expired - Lifetime
- 1993-11-25 PL PL93309222A patent/PL174323B1/pl unknown
- 1993-11-25 RO RO95-00963A patent/RO119280B1/ro unknown
- 1993-11-25 DK DK94900254T patent/DK0670719T3/da active
- 1993-11-25 AT AT94900254T patent/ATE191340T1/de active
- 1993-11-25 JP JP51291494A patent/JP3768231B2/ja not_active Expired - Lifetime
- 1993-11-25 SI SI9300614A patent/SI9300614A/sl unknown
- 1993-11-25 UA UA95058430A patent/UA45948C2/uk unknown
- 1993-11-25 ZA ZA938832A patent/ZA938832B/xx unknown
- 1993-11-25 WO PCT/GB1993/002425 patent/WO1994012164A1/fr active IP Right Grant
- 1993-11-25 AP APAP/P/1993/000592A patent/AP517A/en active
- 1993-11-25 HU HU9501537A patent/HU225918B1/hu unknown
- 1993-11-25 RU RU95113501A patent/RU2108092C1/ru active
- 1993-11-25 TW TW082109940A patent/TW253835B/zh not_active IP Right Cessation
- 1993-11-25 MX MX9307402A patent/MX9307402A/es unknown
- 1993-11-25 SK SK570-95A patent/SK281559B6/sk not_active IP Right Cessation
- 1993-11-25 MY MYPI93002479A patent/MY114241A/en unknown
- 1993-11-25 PE PE1993231837A patent/PE55694A1/es not_active IP Right Cessation
- 1993-12-22 SA SA93140434A patent/SA93140434B1/ar unknown
-
1995
- 1995-05-19 NO NO19951995A patent/NO313225B1/no not_active IP Right Cessation
- 1995-05-22 BG BG99656A patent/BG62595B1/bg unknown
- 1995-05-26 OA OA60668A patent/OA10352A/en unknown
-
1997
- 1997-10-31 US US08/962,273 patent/US5998449A/en not_active Expired - Lifetime
-
1998
- 1998-04-23 HK HK98103412A patent/HK1004468A1/xx not_active IP Right Cessation
-
1999
- 1999-03-09 CZ CZ1999805A patent/CZ289692B6/cs not_active IP Right Cessation
- 1999-10-01 US US09/409,871 patent/US6166046A/en not_active Expired - Lifetime
-
2000
- 2000-06-22 GR GR20000401440T patent/GR3033745T3/el unknown
- 2000-08-29 CY CY0000044A patent/CY2193B1/xx unknown
- 2000-10-04 US US09/678,485 patent/US6291488B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0123239B1 (fr) | Agents anti-protozoiques | |
OA10352A (en) | Combination of atovaquone with proguanil for the treatment of protozoal infections | |
AU614515B2 (en) | A pharmaceutical combination for the prophylaxis and therapy of malaria | |
HU201672B (en) | Process for producing pharmaceutical compositions comprising podophyllotoxin | |
US5134168A (en) | Phenoxy and phenylthio, amino substituted benzocycloalkane derivatives in the treatment and prevention of drug-resistant protozoal infections | |
EP0572615B1 (fr) | Medicament destiné au traitement des infections protozoales causées par Babesia | |
EP0445141B1 (fr) | Medicaments pour le traitement de la toxoplasmose | |
WO1994003163A1 (fr) | Utilisation de la 2-(4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphtoquinone dans le traitement du cancer | |
CZ242994A3 (en) | 1,4-naphthoquinone derivatives exhibiting anti-protozoic and anti-parasitic activity | |
JPH10509722A (ja) | Pneumocystis carinii感染の治療におけるリファブチンの使用およびリファブチンとアトバクオンとの組み合わせ |